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Abstract
Background
Recent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV trans-
mission by up to 86% for men who have sex with men (MSM), whilst relatively high levels of
PrEP acceptability have been reported to date. This study examines PrEP awareness
amongst sub-groups of MSM communities and acceptability amongst MSM in a low preva-
lence region (Scotland, UK), using a mixed methods design.
Methods
Quantitative surveys of n = 690 MSM recruited online via social and sociosexual media
were analysed using descriptive statistics and multivariate logistic regression. In addition, n
= 10 in-depth qualitative interviews with MSM were analysed thematically.
Results
Under one third (29.7%) of MSM had heard of PrEP, with awareness related to living in
large cities, degree level education, commercial gay scene use and reporting an HIV test in
the last year. Just under half of participants (47.8%) were likely to use PrEP if it were avail-
able but there was no relationship between PrEP acceptability and previous PrEP aware-
ness. Younger men (18–25 years) and those who report higher risk UAI were significantly
more likely to say they would use PrEP. Qualitative data described specific PrEP scenarios,
illustrating how risk, patterns of sexual practice and social relationships could affect motiva-
tion for and nature of PrEP use.
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Conclusion
These findings suggest substantial interest PrEP amongst MSM reporting HIV risk behav-
iours in Scotland. Given the Proud results, there is a strong case to investigate PrEP imple-
mentation within the UK. However, it appears that disparities in awareness have already
emerged along traditional indicators of inequality. Our research identifies the need for com-
prehensive support when PrEP is introduced, including a key online component, to ensure
equity of awareness across diverse MSM communities (e.g. by geography, education, gay
scene use and HIV proximity), as well as to responding to the diverse informational and sex-
ual health needs of all MSM communities.
Introduction
Pre-exposure prophylaxis (PrEP) is the use of antiretroviral medication by HIV negative indi-
viduals to reduce the risk of HIV transmission. Findings from iPrEx [1] and other PrEP trials
[2] led the US Food and Drug Administration to approve Truvada1 (emtricitabine/tenofovir
disoproxil fumarate) for use as PrEP in July 2012 [3]. However, to date, PrEP has not yet been
regulated for clinical use in other countries and uptake of PrEP in the US outside of trial set-
tings is limited [4]. A recent Lancet editorial [5] describes access to PrEP as an issue of equity
and human rights, calling on global health organizations, national health policy makers and
pharmaceutical manufacturers to increase and expand PrEP access across low, middle and
high income countries. Such large scale implementation requires a better understanding of
PrEP acceptability amongst potential users.
In Scotland, just under half (47%) of new HIV infections occurred amongst men who have
sex with men (MSM) in 2014 [6]. MSM are disproportionately affected by HIV infection glob-
ally [7], and are generally seen as the key subgroup for PrEP intervention in high-income coun-
tries [8–10]. Recent British [8] and French [9] trials have demonstrated that PrEP can reduce
HIV transmission amongst MSM by up to 86%. Reviews of PrEP acceptability research
amongst MSM found that whilst PrEP awareness was consistently low (14%-25%), PrEP
acceptability (predominantly assessed through likelihood, or willingness, of use) varied consid-
erably (28%-80%; most over 50%) [11,12]. Although multiple demographic and psycho-social
factors have been associated with willingness to use PrEP, including lower levels of education,
younger age and reporting UAI, no strong similarities emerged across these studies [11,12].
Within the UK, surveys of MSM found that reported HIV-risk behaviour and regular testing/
sexual health clinic attendance were significant factors in PrEP acceptability [10,13].
Given the relatively high levels of PrEP acceptability reported to date, there is a need to bet-
ter understand which sub-groups within MSM communities are willing to use PrEP and why.
The aim of the current study is to explore PrEP awareness and acceptability amongst MSM in a
low prevalence region (Scotland, UK), combining qualitative and quantitative data. Scotland
has stable HIV prevalence [14] and an on-going yet stable undiagnosed fraction, which sug-
gests continued incidence [15]. Our comprehensive methodological approach capitalizes upon
the strengths of diverse data sets to produce a holistic and nuanced understanding of which
subgroups of MSM are most likely to accept PrEP and to address the complexities of PrEP use
in real life; a critical step in planning effective PrEP implementation.
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Materials and Methods
Study Design
This paper employs a mixed methods design, drawing on two datasets–a cross-sectional survey
and one-to-one semi-structured interviews—which were sequentially collected and concur-
rently analysed.
Survey Data
The SMMASH (Social Media, MSM and Sexual Health) (see S1 Fig for a copy) survey collected
anonymous, self-complete questionnaires from men recruited online via gay-specific sociosex-
ual media websites (Gaydar, Recon and Squirt) and smartphone apps (Grindr and Gaydar)
and Facebook from November 2012 to February 2013. These sociosexual media websites/apps
differ from social media in that they offer primarily sexually, rather than socially, oriented
online interactions. All members of these sociosexual media, which have a minimum user age
of 18, were invited to participate. Facebook adverts targeted only male users aged over 18 who
‘liked’ various gay-related phrases inviting them to participate. Full details of the survey were
provided to participants on the landing webpage, highlighting they were under no obligation to
take part and participation taken as evidence of informed consent. No financial participation
incentive was given. Participants were asked not to complete the questionnaire if they had
already done so but duplicates were not screened for. Fraudulent and partial entries were
screened and deleted.
In total, 1326 men in Scotland completed useable questionnaires. Questionnaires surveyed
demographics (age, residence, education, proximity to and frequency of gay scene use), sexual
health (HIV/STI testing and diagnoses) and sexual behaviour in the previous 12 months. A
measure of unprotected anal intercourse (UAI) with higher risk for HIV infection was created
to include men who reported UAI with2, casual, and/or HIV status unknown/discordant
partners in the previous 12 months (compared with men reporting UAI with 0/1, regular and/
or HIV status known/concordant partners only). These measures were used previously in the
MRC/CSO Gay Bar Studies [15].
A brief description of PrEP was provided: “A drug (called Truvada) has been licensed in
America to reduce the risk of sexually acquiring HIV for people who are HIV negative. This is
known as Pre-Exposure Prophylaxis (PrEP—prophylaxis just means ‘prevention’). In order for
the drug to work properly, it needs to be taken once a day and never missed. It can reduce the
chance of HIV infection for men who have sex with men by 73% if taken every day. It doesn’t
have any serious side effects but it can cause nausea in the first month for about 10% of people
who take it. The drug is not yet available in the UK.” (Note, This figure of 73% was accurate
at the time of data collection [1]). PrEP awareness was assessed by asking whether partici-
pants had previously heard of PrEP (Response: Yes, No, Unsure). Answers were recoded
into two categories: ‘unsure / had not heard of PrEP’ vs ‘heard of PrEP’. PrEP acceptability
was assessed by asking participants about their likelihood of PrEP use if it were available
today, assessed on a 7 point Likert Scale from extremely likely to extremely unlikely, subse-
quently recoded into 3 categories; likely, unsure and unlikely to create a simpler variable
with more equal group sizes. Development of these PrEP awareness and acceptability ques-
tions was informed by a recent systematic review of PrEP awareness and acceptability studies
[11]. Ethical approval was granted by Glasgow Caledonian University School of Health and
Life Sciences Ethics Subcommittee (HLS id: B11/59) and consent assumed by survey
participation.
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Qualitative Data
We conducted in-depth interviews (IDIs) with communities affected by HIV in the UK (MSM
and migrant African men and women) as part of a wider qualitative study exploring the accept-
ability of PrEP and Treatment as Prevention (TasP) in Scotland. Inclusion criteria for interview
participants was to be 18 years or older, live in Scotland and to identify as either gay, bisexual
or be a man who has sex with men (any ethnicity) or to be a man or a woman born in Africa
but living in Scotland. For the purposes of this analysis, we draw on a interview data with HIV-
negative and/or untested MSM participants. Participants were recruited through community,
health and social media channels between March and September 2013. Exploration of the
acceptability of PrEP included discussions concerning awareness, potential use, concerns and
combination with existing risk management strategies. IDIs were digitally recorded, tran-
scribed verbatim and transcripts were anonymised to ensure participant confidentiality. Writ-
ten consent was provided by all participants and ethical approval was obtained from the
University of Glasgow’s College of Social Sciences Ethics Committee (CSS2012/0193,
CSS20120264). Further details on methods, including explanatory descriptions and interview
schedule can be found elsewhere [16].
Data Analyses
The qualitative and quantitative data sets were analysed concurrently. Quantitative data were
analysed with IBM SPSS 21 by the first author. Men who were HIV positive (n = 75) were
excluded from this analysis as were men with missing data on any of the regression variables
(n = 561) leaving a sample size of 690 participants. This included 599 (86.8%) men who
reported they were HIV-negative and 91 (13.2%) who were untested/unsure of their HIV sta-
tus. Chi-square tests were used for bivariate comparisons. Variables significant at the bivariate
level (p<0.05) were entered into two logistic regression models used to estimate odds ratios
(OR) and 95% confidence intervals (CI) for PrEP awareness and acceptability. T-test and Chi2
analyses were used to compare the demographic and behavioural differences between partici-
pants included in the analysis (n = 690) with those excluded due to missing data (n = 561).
Simultaneously, qualitative data were analysed thematically drawing on both anticipated
and emergent themes [17,18]. Once a full set of themes were established, anonymised tran-
scripts were added to and coded in Nvivo 10, a qualitative data software management package.
Themes were justified and consistently applied using analytical memorandum. Transparency
of coding was established through use of NVivo 10. Rigour throughout the analysis was
achieved through an iterative process of discussion and revision between co-authors [17,19].
Integrating the findings. Following separate data analyses, the findings were combined.
For the purposes of this paper, we identified relevant themes from the qualitative analysis that
further explained or provided more nuance to the quantitative results. In particular, we looked
specifically at themes from the qualitative analysis in relation to awareness of PrEP and likeli-
hood of PrEP use, and drew on these to provide illustrative examples of how PrEP might be
used and in what context.
Results
Participants
Survey sample. The characteristics of the survey sample are shown in Table 1. The mean
age of men sampled was 37 years (range 18–84, SD = 12.9), 97.7% were white and whilst most
(82.3%) were gay identified, one in six were bisexual (16.8%) and several identified as straight
(0.9%). Over half (59.6%) were single but 31.9% had a regular male partner or civil partner
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Table 1. Survey Sample Characteristics (N = 690).
n %
Age
18–25 164 23.8
26–35 181 26.2
36–45 143 20.7
46+ 202 29.3
Ethnicity
White 670 97.7
Black 2 0.3
Asian 5 0.7
Mixed / other 9 1.3
Sexual Orientation
Gay 568 82.3
Bisexual 116 16.8
Straight 6 0.9
Relationship Status
Single 411 59.6
Regular Male Partner / Civil Partnership 220 31.9
Regular Female Partner / Married to a woman 59 8.6
Education
Secondary 83 12.0
Further 141 20.4
Degree 466 67.5
Postcode
Glasgow 216 31.3
Edinburgh 182 26.4
Rest of Scotland 292 42.3
Gay scene use
Never 273 39.6
Once a month or less 263 38.1
At least twice a month 154 22.3
Proximity to gay scene
Too far 318 46.1
Near 372 53.9
Higher risk UAI in the previous 12 months
Yes 233 33.8
No 457 66.2
STI Test in the previous 12 months
Yes 303 43.9
No 387 56.1
STI in the previous 12 months
Yes 65 9.4
No 625 90.6
HIV test in the previous 12 months
Yes 323 46.8
No 367 53.2
Previously heard of PrEP
Yes 205 29.7
(Continued)
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(necessarily same-sex, in current UK law) and 8.6% had a regular female partner or were mar-
ried to a woman. Over two-thirds had degree or postgraduate level education. Participants
were drawn almost evenly from Glasgow (31.3%) and Edinburgh (26.4%), Scotland’s two larg-
est cities, with a further 42.3% from the rest of the country. Most men infrequently used the
commercial gay scene (defined herein as gay bars, clubs and saunas), leading us to collapse this
into a bivariate measure of either Never (n = 273; 39.6%) or Ever (n = 417, 60.4%). Just under
half said that their nearest commercial gay scene was not within easy reach. One third reported
higher risk UAI, just under half reported an STI test (43.9%) or an HIV test (46.8%), and just
under 1 in 10 reported a positive STI test in the previous 12 months.
Missing data analysis. Men who were excluded from this analysis due to missing data
were significantly more likely to report a bisexual or straight identity (Chi2 = 4.62, p = 0.032),
never use the commercial gay scene (chi2 = 5.24, p = 0.022), report no high risk UAI (Chi2 =
11.91, p = 0.001), no STI (Chi2 = 4.67, p = 0.027) or HIV test (Chi2 = 8.01, p = 0.005) test in the
last year. However, they were no more likely to have heard of PrEP (Chi2 = 0.87, ns) nor report
they were likely to use PrEP (Chi2 = 0.05), p = 0.829)
Qualitative sample. We draw on IDI data from a larger qualitative study of communities
affected by HIV in Scotland (n = 34). The sample for this combined analysis includes 10 HIV
negative/status unknown MSM aged between 19 and 52 years (median 27.5 years), resident
across four urban and semi-urban Scottish regions. Participants identified as gay (n = 9) or
bisexual (n = 1), white (n = 9) and British (n = 7). We did not collect information on income or
education levels as part of the qualitative study.
Understanding PrEP awareness amongst MSM in Scotland
Two-hundred and five men (29.7%) had heard of PrEP, 20 (2.9%) were unsure and 465 (67.4%)
had not (see Table 1). Table 2 shows the factors associated with participants’ awareness of
PrEP. When controlling for the factors significant at the bivariate level in the multivariate logis-
tic regression, the adjusted odds of having heard of PrEP remained significantly higher for men
living in Glasgow (AOR = 2.1) and Edinburgh (AOR = 1.94) compared to the rest of Scotland,
men who had degree level education (AOR = 3.68) compared to secondary level education,
men who ever used the commercial gay scene (AOR = 1.49) and men who reported an HIV test
in the previous 12 months (AOR = 2.25). However, PrEP awareness was not related to higher
risk UAI in the multivariate model.
Illuminating these findings further, qualitative analysis suggested that PrEP awareness was
also affected by proximity to HIV. Of the few participants who had heard of PrEP, most were
likely to be HIV-positive, have friends who were, or who worked in field of sexual health.
“Talking to my friend at [a sexual health charity in England]. . .He started talking to me a lot
about the prevention pill. This is getting them all quite excited and, you know, they’re talking
Table 1. (Continued)
n %
No 465 67.4
Unsure 20 2.9
Likelihood of using PrEP if it were available today
Likely 330 47.8
Uncertain 171 24.8
Unlikely 189 27.4
doi:10.1371/journal.pone.0151385.t001
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Table 2. Factors associated with Awareness of PREP (N = 690).
Heard of PrEP (n = 205, 29.7%), n
(%)
Unaware of PrEP (n = 485, 70.3%), n
(%)
Bivariate Regression
Analyses
Multivariate Regression
Analyses
Age OR 95% CI p
value
AOR 95% CI p
value
18–25 41 (20) 123 (25.4) 1 0.246
26–35 60 (29.3) 121 (24.9) 1.49 (0.93–
2.38)
0.098
36–45 48 (23.4) 95 (19.6) 1.52 (0.92–
2.49)
0.100
46+ 56 (27.3) 146 (30.1) 1.15 (0.72–
1.84)
0.557
Postcode
Rest of Scotland 60 (29.3) 232 (47.8) 1 <0.001 0.002
Glasgow 79 (38.5) 137 (28.2) 2.23 (1.5–3.32) <0.001 2.1 (1.34–
3.27)
0.001
Edinburgh 66 (32.2) 116 (23.9) 2.2 (1.45–
3.33)
<0.001 1.94 (1.22–
3.08)
0.005
Sexual Orientation
Bisexual /
Straight
26 (12.7) 96 (19.8) 1
Gay 179 (87.3) 389 (80.2) 1.7 (1.06–
2.71)
0.026
Relationship
Status
Regular female
ptr
9 (4.3) 50 (10.3) 1 0.038
Single 124 (60.5) 287 (59.2) 2.4 (1.45–
5.03)
0.020
Regular male ptr 72 (35.1) 148 (30.5) 2.7 (1.26–5.8) 0.011
Education
Secondary 11 (5.4) 72 (14.8) 1 <0.001 1 <0.001
Further 32 (15.6) 109 (22.5) 1.92 (0.91–
4.06)
0.087 2.08 (0.96–
4.52)
0.058
Degree 162 (79) 304 (62.7) 3.49 (1.8–6.77) <0.001 3.68 (1.85–
7.32)
<0.001
Gay scene use
Never 62 (30.2) 211 (43.5) 1 1
Ever 143 (69.8) 274 (56.5) 1.78 (1.25–
2.52)
0.001 1.49 (1.02–
2.17)
0.039
Proximity to gay scene
Far 76 (37.1) 242 (49.9) 1
Near 129 (62.9) 243 (50.1) 1.69 (1.21–
2.36)
0.002
Had any higher risk UAI*
No 125 (61) 332 (68.5) 1
Yes 80 (39) 153 (31.5) 1.39 (0.99–
1.95)
0.058
Talked about HIV with UAI partners
Never 25 (12.2) 78 (16.1) 1 0.013
No UAI 99 (48.3) 270 (55.7) 1.14 (0.69–1.9) 0.602
Always/
Sometimes
81 (39.5) 137 (28.2) 1.85 (1.09–
3.13)
0.023
(Continued)
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a lot about that”
(IDI, 46+ years).
Understanding the likelihood of PrEP use
Half of the survey participants (47.8%) reported being likely to use PrEP if it were available
today, whilst one quarter (24.8%) were uncertain and one quarter (27.4%) unlikely to use it
(see Table 1). Table 3 shows the factors associated with participants’ likelihood of PrEP use if it
were available today, comparing men who were ‘likely’ to use PrEP (47.8%) with those who
were ‘unlikely/unsure’ (52.2%). When controlling for the factors significant at the bivariate
level in the multivariate logistic regression, the adjusted odds of the likelihood of PrEP use
remained significantly higher for men aged 18–25 compared to men in the three older age
groups (25–35 AOR = 0.61; 36–45 AOR = 0.47; 46+ AOR = 0.54) and for men who reported
any higher risk UAI in the previous 12 months (AOR = 2.27). Finally, awareness of PrEP was
not associated with the likelihood of PrEP use.
Qualitative data analyses enhance these population level findings by suggesting motivation
for potential PrEP use. Participants described the specific scenarios in which they would con-
sider using PrEP, illustrating how the social complexities of risk and sex could be critical factors
in decisions about potential use. Motivation was often identified in relation to the use or non-
use of condoms. For example, PrEP could be seen as a ‘back-up’ option for men who would
regularly use condoms.
“I perceive myself as a condom user with occasional lapses. I’d have thought that’s the sort of
person who would benefit most from PrEP if it works”
(IDI, 46+ years).
Similarly, some men identified PrEP as ideal for situations where regular patterns of sexual
practice, and related condom use, might be disrupted, such as holidays or in the case of alcohol
and/or drug use.
Table 2. (Continued)
Heard of PrEP (n = 205, 29.7%), n
(%)
Unaware of PrEP (n = 485, 70.3%), n
(%)
Bivariate Regression
Analyses
Multivariate Regression
Analyses
Had an STI Test in the previous 12 months
No 93 (45.4) 294 (60.6) 1
Yes 112 (54.6) 191 (39.4) 1.85 (1.33–
2.58)
<0.001
Had an STI in the previous 12 months
No 180 (87.8) 445 (91.8) 1
Yes 25 (12.2) 40 (8.2) 1.55 (0.91–
2.62)
0.107
Had an HIV test in the previous 12 months
No 79 (38.5) 288 (59.4) 1
Yes 126 (61.5) 197 (40.6) 2.33 (1.67–
3.26)
<0.001 2.25 (1.28–
3.95)
0.005
OR = odds ratio; AOR = adjusted odds-ratio; 95% CI = 95% confidence interval.
*UAI with 2 or more partners, UAI with casual partners, and/or UAI with unknown/discordant partners in the previous 12 months.
doi:10.1371/journal.pone.0151385.t002
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Table 3. Factors associated with the acceptability of PrEP use (N = 690).
Willing to use PrEP (n = 330,
47.8%), n (%)
Unsure/ Unlikely to take PrEP (n = 360,
52.2%), n (%)
Bivariate Regression
Analyses
Multivariate
Regression Analyses
Age OR 95% CI p
value
AOR 95% CI p
value
18–25 97 (29.4) 67 (18.6) 1 0.008 1 0.007
25–35 85 (25.8) 96 (26.7) 0.61 (0.4–
0.94)
0.024 0.61 (0.4–
0.95)
0.028
36–45 60 (18.2) 83 (23.1) 0.5 (0.32–
0.79)
0.003 0.47 (0.30–
0.75)
0.001
46+ 88 (26.7) 114 (31.7) 0.53 (0.35–
0.81)
0.003 0.54 (0.35–
0.82)
0.004
Postcode
Rest of Scotland 138 (41.8) 154 (42.8) 1 0.967
Glasgow 104 (31.5) 112 (31.1) 1.04 (0.72–
1.47)
0.843
Edinburgh 88 (26.7) 94 (26.1) 1.05 (0.72–
1.51)
0.817
Sexual
Orientation
Bisexual/
Straight
64 (19.4) 58 (16.1) 1
Gay 266 (80.6) 302 (83.9) 0.8 (0.54–
1.18)
0.259
Relationship
Status
Regular female
ptr
31 (9.4) 28 (7.8) 1 0.511
Single 200 (60.6) 211 (58.6) 0.86 (0.5–
1.48)
0.577
Regular male ptr 99 (30) 121 (33.6) 0.74 (0.42–
1.31)
0.303
Education
Secondary 41 (12.2) 42 (11.7) 1 0.954
Further 67 (20.3) 74 (20.6) 0.93 (0.54–
1.60)
0.786
Degree 222 (67.3) 244 (67.8) 0.93 (0.58–
1.49)
0.768
Gay scene use
Never 124 (37.6) 149 (41.4) 1
Ever 206 (62.4) 211 (58.6) 1.17 (0.86–
1.59)
0.306
Proximity to gay scene
Far 146 (44.2) 172 (47.8) 1
Near 184 (55.8) 188 (52.2) 1.15 (0.85–
1.56)
0.352
Had any higher risk UAI*
No 193 (58.5) 264 (73.3) 1 1
Yes 137 (41.5) 96 (26.7) 1.95 (1.42–
2.69)
<0.001 2.27 (1.37–
3.78)
0.002
Talked about HIV with UAI partners
Never 58 (17.6) 45 (12.5) 1 0.015
No UAI 158 (47.9) 211 (58.6) 0.58 (0.37–
0.90)
0.016
(Continued)
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“If I was aware of [PrEP] before and . . . I was going on holidays or something like that, I
think I would make sure that I would have . . . enough for when I’ve been away or if I was at
any risk, I think I would definitely avail of [PrEP] and make sure that I had it in place. But
again personally, if I was having a few drinks and I knew I was having [PrEP] I probably still
wouldn’t comply with the condoms,my foolishness in the past [is evidence] of that”
(IDI, 18–25 years).
Motivation for PrEP use was also identified in relation to sexual partners and the nature of
sexual relationships. Some men suggested they might specifically use PrEP in a sexual relation-
ship with a known HIV-positive sexual partner.
“I mean if that was available, and say I was going out with somebody that was HIV positive. I
would take that, and—without a doubt I would take that. I’ve no concern whatever for the
sake of swallowing one pill a day”
(HIV-negative MSM, IDI, 18–25 years).
In contrast, others felt that PrEP was only a short-term solution to HIV prevention, and
therefore, something they would use for casual sexual encounters with partners of unknown
sero-status.
“I would definitely consider it more of an outside [of] relationship thing and if I was being,
going back to the word, promiscuous I think I would definitely, yeah, I would, I would feel
much more reassured knowing that that was there. It’s kind of like a wee bit further on from
PEP [Pre-Exposure Prophylaxis]”
(IDI, 18–25 years).
Table 3. (Continued)
Willing to use PrEP (n = 330,
47.8%), n (%)
Unsure/ Unlikely to take PrEP (n = 360,
52.2%), n (%)
Bivariate Regression
Analyses
Multivariate
Regression Analyses
Always/
Sometimes
114 (34.5) 104 (28.9) 0.85 (0.53–
1.36)
0.501
Had an STI Test in the previous 12 months
No 178 (53.9) 209 (58.1) 1
Yes 152 (46.1) 151 (41.9) 1.18 (0.88–
1.6)
0.277
Had an STI in the previous 12 months
No 294 (89.1) 331 (91.6) 1
Yes 36 (10.9) 29 (8.1) 1.4 (0.84–
2.34)
0.201
Had an HIV test in the previous 12 months
No 170 (51.5) 197 (54.7) 1
Yes 160 (48.5) 163 (45.3) 1.14 (0.84–
1.54)
0.399
Heard of PrEP
No / Unsure 231 (70) 254 (70.6) 1
Yes 99 (30) 106 (29.4) 1.03 (0.74–
1.42)
0.873
OR = odds ratio; AOR = adjusted odds-ratio; 95% CI = 95% confidence interval.
*UAI with 2 or more partners, UAI with casual partners, and/or UAI with unknown/discordant partners in the previous 12 months
doi:10.1371/journal.pone.0151385.t003
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In summary, whilst quantitative data suggested that only younger age and reporting higher
risk UAI increased men’s likelihood of using PrEP, qualitative data further illustrated how the
complex interplay of risk perception, patterns of sexual practice and social relationships could
influence the motivation for and nature of PrEP use.
Discussion
This is the first mixed methods study to consider awareness and acceptability of PrEP in the
UK. Amongst MSM in Scotland, awareness of PrEP was associated with living in large cities,
higher levels of educational attainment, using the commercial gay scene and taking an HIV test
within the last year. In terms of understanding who would use PrEP, once made aware of it,
younger men and those reporting higher risk UAI within the previous year were most likely to
say they would use it. Qualitative analysis demonstrated how motivation was tied to patterns of
condom use and sexual relationships (e.g. with known HIV positive partners, as an emergency
back-up system and episodic rather than continuous use). These findings suggest that there is
substantial interest in biomedical HIV risk reduction strategies amongst MSM reporting HIV
risk behaviours in Scotland and, given the efficacy shown by the Proud [8] and Ipergay [9] tri-
als, a case to investigate mainstream PrEP implementation within the UK.
Overall, less than one third (29.7%) of MSM recruited online in Scotland had heard of PrEP,
similar to Scottish men recruited on the commercial gay scene [10] and MSM in other high
income countries (11–23%; [11]; 14–25%; [12,20]). Moreover, our findings suggest structural
factors pattern who currently is aware of PrEP, including greater urbanicity, higher educational
qualifications, sexual health literacy (as reflected by recent HIV testing), HIV proximity and
embeddedness within gay communities. Although these associations resonated with previous
studies, little consistency in the relationship between PrEP awareness, sociodemographic and
behavioural variables has been shown [12] even amongst MSM within Scotland [10]. Despite
little PrEP engagement from health promotion agencies worldwide, it appears that disparities
in awareness have already emerged along traditional indicators of inequality. Clearly, a chal-
lenge to PrEP implementation is to promote PrEP to men who are not reached through work
within traditional MSM locations such as large cities, the commercial gay scene and STI clinics.
Since almost 80% of our online survey participants rarely or never use the commercial gay
scene, digitally mediated social and gay sociosexual networks offer one a promising solution.
Online campaigns can be geographically targeted to consumers outwith large urban centres
and would also provide access to younger MSM, who use sociosexual networks more often
than older men [21]. As such, a broad, multimedia social marketing campaign, encapsulating
both traditional (commercial gay scene and STI clinics) and digital (social and sociosexual
media) marketing designed to reach MSM is warranted. Crucially, in order for PrEP to be tar-
geted appropriately and used effectively, widening PrEP awareness is a necessary first step.
Almost half of participants (47.8%) reported that they would use PrEP if it were available
today. This high level of interest in PrEP is similar to research with Scottish men recruited on
the commercial gay scene [10] as well as multiple studies conducted with MSM elsewhere
[11,12]. Amongst our respondents, younger men and those who report higher risk UAI were
significantly more willing to adopt PrEP. Multiple studies corroborate this relationship
between younger age [10,13,22–24], UAI [10,13,23–28] and PrEP acceptability, with relatively
few studies reporting no age based such relationship [29] or significant alternative demo-
graphic or behavioural relationships [10]. This level of interest amongst men reporting higher-
risk UAI in our study suggests that PrEP could be an acceptable prevention method to those
currently at risk of HIV, echoing previous findings [12,29]. Moreover, since both the Proud [8]
and Ipergay [9] trials suggested that PrEP efficacy is somewhat higher than the 73% suggested
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in our questionnaire, and that intermittent use is equally effective, our PrEP acceptability rate
is likely an under-estimate.
Finally, it is important to highlight that awareness of PrEP was not related to PrEP accept-
ability. This reinforces the notion that information alone is insufficient to support PrEP usage
and underlines the need for both awareness-raising and support for PrEP use to enable cost-
effective targeting. In particular, those motivating factors identified in our research, including
the role of PrEP in diverse sexual relationships, and episodic or ‘emergency’ cases, will need to
be addressed therein.
Limitations
Our novel combination of quantitative and qualitative data allowed us to examine both popula-
tion level findings and in-depth subjective understandings. It was not possible to calculate a
response rate for the quantitative data given the nature of online surveys, and men’s use of mul-
tiple sites/profiles. However, the sample size achieved herein is comparable to other surveys of
MSM in Scotland [15] and other comparable countries [30]. It is also clear that our findings
rely on men’s estimates of their future behaviour, rather than any objective measure of actual
behaviour. Nonetheless, the current absence of PrEP availability means that such estimates rep-
resent the only population level evidence to inform subsequent PrEP provision. Missing data
were high for variables in our final regression analyses and significant demographic and beha-
vioural differences between those men excluded and included were apparent which limit the
validity of our results. The small sample size of the study’s qualitative component, and recruit-
ment of some participants who were already engaged in sexual health services, limit the gener-
alisability of these qualitative findings to a wider population of MSM. However, we would
argue they are transferrable to similar populations and help to further elucidate the population
level findings. The key HIV behavioural risk measure adopted herein is limited in scope, since
by dichotomising risk it elides more nuanced analysis of degrees of risk. Equally, it blurs the
distinction between numbers of unprotected partners and unprotected acts, the latter of which
is a more accurate risk indicator. Furthermore, it restricts risk estimates to a fixed time span of
the previous 12 months. Although behavioural risks over a longer period are relevant in terms
of HIV risk at the individual level, retrospective estimates of population behaviour are likely to
become increasingly inaccurate as the recall period increases. Finally, whilst it should be noted
that there are often differences between anticipated and actual behaviour–the ‘intention-beha-
vioural gap’ often discussed in health psychology [31], rather than representing predictive
research, our analysis attempts to indicate potential PrEP interest and identify those issues to
be considered in relation to future PrEP implementation. Indeed, we would argue that potential
PrEP use is underpinned by a complex interplay of social context, risk management strategies
and relationship status, alongside demographic characteristics and behavioural intentions.
Implications
Awareness of PrEP remains modest amongst MSM in Scotland, though willingness to use
PrEP is relatively high. Two key groups emerged as most likely to be willing to adopt PrEP;
younger MSM and MSM who report higher risk UAI in the previous year. This is encouraging
since the latter group are those very men most likely to benefit from PrEP use. Mixed responses
to PrEP in conjunction with condom use indicate a range of combination prevention PrEP
strategies will be employed by potential PrEP users. Some men viewed PrEP as incompatible
with condom use, whilst others felt it provided a ‘safety net’ in terms of additional prevention.
These findings have important policy implications for HIV prevention in the UK, as well as
other similar low prevalence, high income and geographically dispersed contexts, such as
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Australia, New Zealand and Canada. Our research identifies the need for comprehensive sup-
port, including a key online component, when PrEP is introduced to ensure equity of aware-
ness across diverse MSM communities (e.g. by geography, education levels, gay scene use and
HIV proximity), as well as to respond to the diverse informational and sexual health needs of
all MSM communities.
It is vital to consider PrEP amidst the increasing complexity of HIV prevention, and inter-
sectionality with diverse risk management strategies (e.g. seroadaptive behaviours). Critically,
within the context of correct PrEP use, condomless anal intercourse no longer represents a
higher risk behaviour for HIV infection, but instead is part of a safer sexual strategy. As such,
‘high risk’men might incorporate new strategies as described herein (e.g. episodic PrEP, either
with positive partners or as a back-up) which changes the risk in specific sexual acts and may
explain their interest in PrEP [23,29]. Certainly, MSM who came forwards to participate in the
UK PROUD study could be categorised as ‘very high HIV risk’ in terms of their UAI behaviour
[32]. Moreover, recent discussions have focused on this episodic PrEP strategy during periods
of risk [33] as described by our participants. This highlights the importance of considering
multiple PrEP strategies beyond daily, continuous usage. Guidance which embraces episodic
and situation based PrEP use and ‘prevention-effective adherence’ [33], alongside the sustained
PrEP use model currently envisaged, will more closely meet MSM’s own behavioural expecta-
tions. Moreover, such guidance must relate to the contextual and temporal specifics of PrEP
implementation amongst those who need it most. Crucially, such complex risk management
strategies, including PrEP, TasP, regular HIV testing and condom use require high levels of
HIV literacy throughout the MSM population in order to effectively reduce HIV incidence.
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